Question 1 · choose 1
A pharmaceutical company has a dozen AI pilots, each approved informally by whichever executive sponsored it. Nobody can say who is accountable when a pilot causes a problem. The CEO asks for a governance structure. What should the company establish?
- AAn approval process run by the IT department alone, because AI is a technology
- BA rule that each pilot's executive sponsor approves its own pilot as before
- CA cross-functional AI oversight committee with defined roles and a RACI matrix
- DAn external auditor who reviews every AI system once a year
Show the answer and why
AAn approval process run by the IT department alone, because AI is a technology
Incorrect
AI decisions involve legal, compliance, security and business risk. An IT-only body lacks the representation those decisions need.
BA rule that each pilot's executive sponsor approves its own pilot as before
Incorrect
This is the current informal arrangement that leaves accountability unclear when something goes wrong.
CA cross-functional AI oversight committee with defined roles and a RACI matrix
Correct
AWS's maturity guidance calls for a cross-functional oversight committee for AI implementation reviews and a signed-off RACI matrix that makes responsibilities explicit.
DAn external auditor who reviews every AI system once a year
Incorrect
External audits provide assurance, but an annual review is not an internal structure that decides and owns AI matters day to day.
Effective AI governance brings together the functions affected by AI, including business, technology, legal, compliance and security, and makes accountability explicit. A cross-functional committee plus a RACI matrix answers the question of who decides and who is accountable.
AWS documentation